# PharmaCyte Biotech, Inc.: Form 8-K, filed Sep 15, 2010

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2010-09-15
- Accepted by EDGAR: Sep 15, 2010, 14:46 ET
- Period: 2010-09-14
- Accession: 0001099910-10-000137
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000109991010000137/nuvilex_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000109991010000137/

## Items reported

- Item 3.01: Delisting notice
- Item 4.02: Non-reliance on financial statements
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000109991010000137/nuvilex_8k.htm

Filed Sep 15, 2010.
Source: SEC EDGAR, the filing index for accession 0001099910-10-000137. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
